There are seven types of submissions for IRB review; numbers 1-3 pertain to new studies:

1. Full Committee review: including new studies that involve more than minimal risk; use of new drugs, investigational devices, drug-sponsored studies, etc.

2. Expedited review: studies involving no more than minimal risk (final determination of whether the study qualifies as "expedited" is made by the IRB Chair).

3. Exempt Status: Administrative Review Form

4. Emergency Use Request: a life-threatening situation in which no standard acceptable treatment is available and in which there is not sufficient time to obtain IRB approval Emergency Use Guidelines

5. Protocol amendment or modification

6. Progress Reports/Continuing Review (completed on an annual basis)

7. Unanticipated Risks or Adverse Events Reports (completed on an annual basis)

Submit to:
IRB Coordinator,
2200 Webster Street, 5th Floor
San Francisco, CA 94115
(415) 600-3688